ArticleJournal of pain research2026
Efficacy and Spinal Noradrenergic Mechanisms of Contralateral Melittin Acupuncture Against Paclitaxel-Induced Peripheral Neuropathic Pain in Rats.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Paclitaxel-induced peripheral neuropathy is a leading cause of premature discontinuation of taxane-based chemotherapeutic regimens. Studies have affirmed the analgesic properties of bee venom-containing pharmacoacupuncture, demonstrating that anti-nociceptive effects occur following melittin treatment at the ipsilateral ST36 (Zusanli acupoint). However, current understanding of the therapeutic potential of melittin-based approaches for the contralateral side is limited. Objective: This study comprehensively explored the analgesic potential and central mechanisms of melittin pharmacoacupuncture using behavioral, in vivo electrophysiological, and neuropharmacological techniques in rats with paclitaxel-induced peripheral neuropathy, focusing on the contralateral limb. Methods: Neuropathic signs following intraperitoneal paclitaxel regimens were quantified on the right-hind paw of rats using acetone drop and von Frey filament experiments. In vivo electrophysiological single-cell recordings of spinal wide-dynamic-range (WDR) neurons were made from the right-dorsal horn extracellularly (n=9-10/group). Melittin was administered subcutaneously at the ST36 acupoint on the left-hind limb (n=7/group). For neuropharmacological analysis, prazosin (an α1-adrenoceptor antagonist) or idazoxan (an α2-adrenoceptor antagonist) was administered before apitherapy (n=6/group). Results: Following contralateral melittin treatments, a marked attenuation of peripheral cold and mechanical hypersensitivities, along with a sustained reversal of central sensitization in WDR neurons in response to peripheral cutaneous stimuli, was observed in neuropathic rodents after apitherapy. Melittin-induced analgesia involved central noradrenergic mechanisms: its effects on mechanical allodynia and hyperalgesia were counteracted by spinal α2-adrenoceptor antagonism, and its effects on cold allodynia were dependent on activation of spinal α1- and α2-adrenoceptors. Conclusion: Applications of melittin to ST36 modulated spinal α1- and α2-adrenoceptors. This modulation induced a significant reorganization of nociceptive processing within dorsal horn pain-transmitting neurons, leading to attenuated neuropathic signs in the contralateral limb of rats. Collectively, our behavioral and neurophysiological findings provide pre-clinical evidence supporting melittin-based pharmacoacupuncture as a potential therapy for paclitaxel-induced neuropathic pain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.